E 200

Vitamin E [Alpha Tocopherol Acetate] ·Bristol Pharmaceuticals Ltd.·Chewable Tablet

0 views 0 reviews

Packages & prices

Pack	Price	Details
Unit Price	৳	Unit Price: ৳ 3.33 (30's pack: ৳ 100.00)

Administration

Age-related Macular Degeneration: Vitamin E 400-600 IU daily.

Heart Disease (to improve effectiveness of Nitrates): Vitamin E 200 IU three times daily.

Dementia/Alzheimer’s Disease: Vitamin E 800-2000 IU one-two times daily.

Rheumatoid Arthritis Pain: Vitamin E 600 IU daily.

Improving Male Infertility: Vitamin E 200-600 IU daily.

Menstrual Syndrome: Vitamin E 400 IU daily.

Painful Menstrual Period: Vitamin E 200 IU daily.

Effects

Diarrhoea & abdominal pain may occur with doses greater than 1000 IU daily.

Indications

E 200 is indicated for the treatment and prevention of E 200 deficiency. E 200 (d-alpha tocopherol) is also suggested to use as an antioxidant to promote, prevent and treat various health conditions such as-

Alzheimer’s Disease
Rheumatoid Arthritis Pain
Nerve Damage caused by Chemotherapy
Male Infertility
Age-related Macular Degeneration
Keratectomy
Premenstrual Syndrome
Painful Menstrual Periods
Heart Disease (to improve effectiveness of nitrates) etc.

Pharmacology

Vitamin E acts as an antioxidant in the body. Vitamin E protects polyunsaturated fatty acids (which are components of cellular membrane) and other oxygen-sensitive substances such as vitamin A & vitamin C from oxidation. In premature neonates irritability, edema, thrombosis and hemolytic anemia may be caused due to vitamin E deficiency. Creatinuria, ceroid deposition, muscle weakness, decreased erythrocyte survival or increased in vitro hemolysis by oxidizing agents have been identified in adults and children with low serum tocopherol concentrations.

Precautions

E 200 has been reported to increase bleeding tendency in vitamin K deficient patients or those taking anticoagulant treatments, it is therefore recommended to monitor the prothrombin time and international normalised ratio (INR) to detect any changes in haemostasis. E 200 has been reported to increase the risk of thrombosis in patients predisposed to this condition, including patients taking oestrogens. This finding has not been confirmed but should be borne in mind when selecting patients for treatment, in particular women taking oral contraceptives containing oestrogens.